<unk>  is a hydrolytic lysosomal glucocerebroside-specific enzyme that is FDA approved for the treatment of of type 1 Gaucher disease.   Common adverse reactions include pruritus, flushing, headache, arthralgia, pain in extremity, abdominal pain, vomiting, fatigue, back pain, dizziness, nausea and rash.
Taliglucerase alfa
Velaglucerase alfa
Imiglucerase
Alglucosidase alfa
Vestronidase alfa
Tiocarlide
Tolnaftate
Choline alfoscerate